Development of Polysorbate 80/Phospholipid mixed micellar formation for docetaxel and assessment of its in vivo distribution in animal models

Nanoscale Research Letters

Volumn 6, Issue , 2011, Pages 1-12

  Song, Hua ^a,b   Geng, Hongquan ^c   Ruan, Jing ^a,b   Wang, Kan ^a,b   Bao, Chenchen ^a,b   Wang, Juan ^b   Peng, Xia ^b   Zhang, Xueqing ^a,b   Cui, Daxiang ^a,b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE DELIVERY SYSTEM; ANIMAL MODEL; BIODISTRIBUTIONS; BLOOD COMPATIBILITY; CLINICAL PRACTICES; DOCETAXEL; DOSAGE FORMS; IN-VIVO; INTRAVENOUS ADMINISTRATION; INTRAVENOUS INJECTIONS; MEAN SIZE; MIXED MICELLES; NARROW SIZE DISTRIBUTIONS; POLYSORBATE 80; POLYSORBATES; RODLIKE MICELLES; STRUCTURAL CHARACTERISTICS; TAXOTERE; THERAPEUTIC EFFECTS;

BLOOD; PHARMACOKINETICS; PHOSPHOLIPIDS; RATING;

MICELLES;

ANIMALIA;

EID: 84862907882     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-6-354     Document Type: Article

References (24)

1. Cuppone F, Bria E, Carlini P, Milella M, Felici A, Sperduti I, Nistico C, Terzoli E, Cognetti F, Giannarelli D: Taxanes as primary chemotherapy for early breast cancer-Meta-analysis of randomized trials. Cancer 2008, 113:238-246.
2. Ringel I, Horwitz SB: Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol. J Natl Cancer Inst 1991, 83:288-291.
3. Liu C: Research and development of nanopharmaceuticals in China. Nano Biomedicine and Engineering 2009, 1:1.
4. Yanasarn N, Sloat BR, Cui Z: Nanoparticles engineered from lecithin-inwater emulsions as a potential delivery system for docetaxel. Int J Pharm 2009, 379:174-180.
5. Zhai G, Wu J, Xiang G, Mao W, Yu B, Li H, Piao L, Lee LJ, Lee RJ: Preparation, characterization and pharmacokinetics of folate receptortargeted liposomes for docetaxel delivery. J Nanosci Nanotechnol 2009, 9:2155-2161.
6. Liang G, Jia-Bi Z, Fei X, Bin N: Preparation, characterization and pharmacokinetics of N-palmitoyl chitosan anchored docetaxel liposomes. J Pharm Pharmacol 2007, 59:661-667.
7. Kim GH, Lee JY, Kang YM, Kang KN, Kim ES, Kim DY, Kim JH, Kim MS: Preparation and characterization of self-emulsified docetaxel. J Nanomater 2011, 860376.
8. Naik S, Patel D, Surti N, Misra A: Preparation of PEGylated liposomes of docetaxel using supercritical fluid technology. J Supercrit Fluid 2010, 54:110-119.
9. Wang QW, Lu HL, Song CC, Liu H, Xu CG: Radiosensitivity of human colon cancer cell enhanced by immunoliposomal docetaxel. World J Gastroenterol 2005, 11:4003-4007.
10. Yuan ZG, Chen DW, Zhang ST, Zheng ZD: Preparation, characterization and evaluation of docetaxel-loaded, folate-conjugated PEG-liposomes. Yakugaku Zasshi 2010, 130:1353-1359.
11. He C, Zhang L, Wang H, Zhang F, Mo X: Physical-chemical properties and in vitro biocompatibility assessment of spider silk, collagen and polyurethane nanofiber scaffolds for vascular tissue engineering. Nano Biomed Eng 2009, 1:80.
12. Simoes SI, Tapadas JM, Marques CM, Cruz ME, Martins MB, Cevc G: Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween 80. Eur J Pharm Sci 2005, 26:307-317.
13. Chen S, Ji Y, Lian Q, Wen Y, Shen H, Jia N: Gold Nanorods Coated with Multilayer Polyelectrolyte as Intracellular delivery Vector of Antisense Oligonucleotides. Nano Biomed Eng 2010, 2:15.
14. Bagul M, Kakumanu S, Wilson T, Nicolosi R: In vitro evaluation of antiproliferative effects of self-assembling nanoemulsion of paclitaxel on various cancer cell lines. Nano Biomed Eng 2010, 2:11.
15. Song H, Chen JM, Liang HJ, Xu LY: Optimized preparation of docetaxel polysorbate 80/phospholipid mixed micelles injection by uniform design. Chin Pharm J 2008, 48:5.
16. Cortes JE, Pazdur R: Docetaxel. J Clin Oncol 1995, 13:2643-2655.
17. Anton E, Swetha K, Thomas W, Nicolosi R: Dextran-based nanocarriers as efficient media delivery vehicles to cell production bioreactors. Nano Biomed Eng 2010, 2:126.
18. Nishiyama N, Kataoka K: Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther 2006, 112:630-648.
19. Cohen-Sela E, Chorny M, Gutman D, Komemi S, Koroukhov N, Golomb G: Characterization of monocytes-targeted nanocarriers biodistribution in leukocytes in ex-vivo and in-vivo models. Nano Biomed Eng 2010, 2:91.
20. Gul W, Salamone SJ, Courtney JB, Lundell GD, ElSohly MA: Docetaxel immunoassay. United States Patent Application 20080287658 2008.
21. Rao BM, Chakraborty A, Srinivasu MK, Devi ML, Kumar PR, Chandrasekhar KB, Srinivasan AK, Prasad AS, Ramanatham J: A stabilityindicating HPLC assay method for docetaxel. J Pharm Biomed Anal 2006, 41:676-681.
22. Gustafson DL, Long ME, Zirrolli JA, Duncan MW, Holden SN, Pierson AS, Eckhardt SG: Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay. Cancer Chemother Pharmacol 2003, 52:159-166.
23. Zhao L, Wei YM, Zhong XD, Liang Y, Zhang XM, Li W, Li BB, Wang Y, Yu Y: PK and tissue distribution of docetaxel in rabbits after i.v. administration of liposomal and injectable formulations. J Pharm Biomed Anal 2009, 49:989-996.
24. Wang T, Hu Y, Zhang L, Jiang L, He N: Erythropoietin nanopariticles: therapy for cerebral ischemic injury and metabolize in kidney and liver. Nano Biomed Eng 2010, 2:31.